CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 94 filers reported holding CONCERT PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $171,719 | +145.3% | 29,404 | +182.4% | 0.00% | – |
| Q3 2022 | $70,000 | +25.0% | 10,412 | -37.4% | 0.00% | – |
| Q1 2022 | $56,000 | -49.5% | 16,627 | -37.0% | 0.00% | – |
| Q2 2021 | $111,000 | -31.9% | 26,404 | +58.6% | 0.00% | – |
| Q3 2020 | $163,000 | -63.9% | 16,647 | -4.4% | 0.00% | -100.0% |
| Q4 2017 | $451,000 | +46.4% | 17,421 | -14.3% | 0.00% | -50.0% |
| Q1 2015 | $308,000 | – | 20,330 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 1,932,123 | $44,246,000 | 4.48% |
| Ghost Tree Capital, LLC | 350,000 | $8,015,000 | 1.62% |
| INGALLS & SNYDER LLC | 1,322,062 | $30,275,000 | 1.48% |
| SENZAR ASSET MANAGEMENT, LLC | 199,139 | $4,561,000 | 1.44% |
| Matarin Capital Management, LLC | 285,450 | $6,536,805,000 | 0.49% |
| KNOTT DAVID M | 49,557 | $1,135,000 | 0.47% |
| Spark Investment Management LLC | 144,600 | $3,311,000 | 0.21% |
| PRINCETON CAPITAL MANAGEMENT LLC | 16,582 | $380,000 | 0.17% |
| TIVERTON ASSET MANAGEMENT LLC | 77,782 | $1,781,000 | 0.12% |
| CADENCE CAPITAL MANAGEMENT LLC | 82,240 | $1,883,000 | 0.12% |